|
Basel, March 29, 2004
Roche Diagnostics launches a new generation urine test strip
analyzer
Urisys 1100™ Urine Analyzer provides state-of-the-art,
automated urinalysis testing for physicians
Roche Diagnostics announces the newest member of its Urisys™
urine analyzer family - - the Urisys 1100. This user-friendly,
compact and time-saving diagnostic tool offers state-of-the-art
urinalysis for fast and standardized results that allow healthcare
professionals to monitor their patients more easily and efficiently
so they can provide high quality patient care. The Urisys 1100 analyzer
is currently available in the U.S. market.
The Urisys 1100 urine analyzer is ideally suited for physicians'
offices and specialists seeking a cost-effective way to improve
standardization and work flow for urinalysis testing. Additionally
this analyzer can be a system solution for small hospital laboratories
and decentralized testing sites such as hospital floors and occupational
health care units, due to its flexibility in sample identification
and easy integration into the laboratory environment through standard
interfacing.
"This urinalysis diagnostic device is a first step into automation
for physicians' offices, but also for small laboratories with low
work load (10 - 40 samples/day), performing small batches or consecutive
testing", said Dr. Ewald Hohenberger, Senior Marketing Manager
Primary Care for Roche Near Patient Testing.
About Urisys 1100 Urine Analyzer
The CLIA-waived Urisys 1100 urine analyzer is a small, semi-quantitative
analyzer for evaluation of the well-proven Chemstrip® urine
test strips. This analyzer offers flexible strip options with the
capability to read either Chemstrip10MD, Chemstrip 10UA, Chemstrip
7, or Chemstrip 5 OB test strips.
The Urisys 1100 Analyzer features a 100-result memory function,
immediate availability of result printouts, easy cleaning, interfacing
capability to PC or network, as well as quality assurance functions.
This easy-to-use analyzer provides standardized results, eliminates
manual data entry errors, and improves labor efficiency. "Because
of its automated testing, the Urisys 1100 Analyzer enables physicians
and assistants to spend more time with their patients," said
Michael Rasche, Senior Vice President of Roche Near Patient Testing.
"By offering this efficient, convenient, and rapid diagnostic
analyzer with interfacing options for PC and network connectivity,
we are stressing the high level of commitment by Roche Diagnostics
to the urinalysis business and to providing healthcare professionals
with tools that help them deliver actionable information."
About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world's
leading innovation-driven healthcare groups. Its core businesses
are pharmaceuticals and diagnostics. Roche is number one in the
global diagnostics market, the leading supplier of pharmaceuticals
for cancer and a leader in virology and transplantation. As a supplier
of products and services for the prevention, diagnosis and treatment
of disease, the Group contributes on a broad range of fronts to
improving people's health and quality of life. Roche employs roughly
65,000 people in 150 countries. The Group has alliances and research
and development agreements with numerous partners, including majority
ownership interests in Genentech and Chugai. Roche's Diagnostics
Division, the world leader in in-vitro diagnostics with a uniquely
broad product portfolio, supplies a wide array of innovative testing
products and services to researchers, physicians, patients, hospitals
and laboratories world-wide. Roche Diagnostics' U.S. headquarters
is located in Indianapolis, Ind. (www.roche-diagnostics.us).
Near Patient Testing, headquartered in Graz, Austria, brings the
laboratory to the patient by offering a broad range of simple and
reliable point of care systems. The product range consists of cardiac
markers, blood gas and electrolyte analysis, coagulation, urinalysis,
clinical chemistry, immunological tests and convenient connectivity
solutions for use in the hospital, the physician's office or at
home. For further information, please visit our websites www.roche.com
, www.diavant.com
and www.roche-diagnostics.com.
For more information please contact:
Lori LeRoy
Roche Diagnostics
Phone: 317-521-7159
e-mail: lori.leroy@roche.com
URISYS, URISYS 1100 and CHEMSTRIP are trademarks of a Member of
the Roche Group.
|
